APA (7th ed.) Citation

Ishiguro, S., Kawabata, A., Zulbaran-Rojas, A., Monson, K., Uppalapati, D., Ohta, N., . . . Tamura, M. (2018). Co-treatment with a C1B5 peptide of protein kinase Cγ and a low dose of gemcitabine strongly attenuated pancreatic cancer growth in mice through T cell activation. Biochemical & Biophysical Research Communications, 495(1), 962. https://doi.org/10.1016/j.bbrc.2017.11.102

Chicago Style (17th ed.) Citation

Ishiguro, Susumu, et al. "Co-treatment with a C1B5 Peptide of Protein Kinase Cγ and a Low Dose of Gemcitabine Strongly Attenuated Pancreatic Cancer Growth in Mice Through T Cell Activation." Biochemical & Biophysical Research Communications 495, no. 1 (2018): 962. https://doi.org/10.1016/j.bbrc.2017.11.102.

MLA (9th ed.) Citation

Ishiguro, Susumu, et al. "Co-treatment with a C1B5 Peptide of Protein Kinase Cγ and a Low Dose of Gemcitabine Strongly Attenuated Pancreatic Cancer Growth in Mice Through T Cell Activation." Biochemical & Biophysical Research Communications, vol. 495, no. 1, 2018, p. 962, https://doi.org/10.1016/j.bbrc.2017.11.102.